iiinova — where your digital self keeps evolving

Reposted by Joshua Thornsberry

Dr. Monali Desai @drmonalidesai.bsky.social · 05/04/2025

An interesting study looking at using a deep learning model to evaluate ECGs in the emergency room to determine if patients need coronary revascularization as existing methods can sometimes be inconclusive. academic.oup.com/eurheartj/ad...

133

Joshua Thornsberry @thornsberryjd.bsky.social · 30/03/2025

Tomorrow is your last chance to visit this BP measurement learning station at #ACC25! Avoiding common pitfalls is key to accurate care—don’t miss it in the Personalized Skills Center. learn.acc.org/Page/LEARNHTN #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

033

Reposted by Joshua Thornsberry

American College of Cardiology @accintouch.bsky.social · 30/03/2025

ALPACA: The novel extended-duration small interfering RNA lepodisiran reduced mean serum concentrations of Lp(a) from 60 to 180 days after being administered subcutaneously. #ACC25 Learn more about the study ➡️ bit.ly/3Y1DkU7 #CardioSky #MedSky

0125

Reposted by Joshua Thornsberry

JACC Journals @jaccjournals.bsky.social · 30/03/2025

Dr. Victor Dzau presenting his keynote speech, Science, Medicine, and Society: A Brave New World, during the 2025 Eugene Braunwald Keynote happening now! 📍Room S100b #ACC25 #CardioSky

053

Reposted by Joshua Thornsberry

Cristina Popa @nephroseeker.medsky.social · 30/03/2025

FRESH-UP Trial #ACC25 #medsky RCT comparing liberal vs restricted fluid intake (≤1500 ml/d) in 504 pts with stable chronic HF 🌊No difference in status health quantified by Kansas City Cardiomyopathy Questionnaire at 3 mths 🌊 More thirst distress with restriction www.nature.com/articles/s41...

02415

Reposted by Joshua Thornsberry

Catherine Benziger MD MPH FAHA FACC @drbenzigerheart.bsky.social · 30/03/2025

Dr. Victor Dzau: How do we improve #cvd with rising #obesity? ✅Start with 1° and 2° #cvprev ✅Primordial prevention @accintouch.bsky.social #acc25

053

Reposted by Joshua Thornsberry

Catherine Benziger MD MPH FAHA FACC @drbenzigerheart.bsky.social · 30/03/2025

Dr. Victor Dzau: Future of #CVD care is going to be evolving rapidly over the next century: ❤️ Emphasis on prevention ❤️ Equitable access and affordable ❤️ Mission-based innovation ❤️ Develop national priorities Need governance to oversee innovation, ensure ethics #acc25 @accintouch.bsky.social

064

Joshua Thornsberry @thornsberryjd.bsky.social · 30/03/2025

Wellstar team-based care in action at #ACC25! This poster showcases a coordinated strategy to improve SGLT2i use post-AMI—driving better prescribing, education, and follow-up for patients. #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

132

Joshua Thornsberry @thornsberryjd.bsky.social · 30/03/2025

FRESH-UP at #ACC25: No benefit to fluid restriction in HF. No harm with liberal intake. Improved QOL with more fluid freedom. Supports what we have long suspected—and may help shift the standard of care moving forward. #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

133

Reposted by Joshua Thornsberry

Jae Patton 🏳️‍🌈🫀 ❤️‍🔥🏳️‍🌈 @jaepattonnp.bsky.social · 30/03/2025

#ACC25 #LGBTQ work group represents at the Health #Equity Hub! Dr Deb and Dr Coylewright - So proud of the work you’re both doing! @thornsberryjd.bsky.social @brototod.bsky.social

051

Reposted by Joshua Thornsberry

Jae Patton 🏳️‍🌈🫀 ❤️‍🔥🏳️‍🌈 @jaepattonnp.bsky.social · 30/03/2025

Join us for this exciting session on management of CIEDs in complex patients - #ACC25 #CIED #cardiopalli #SDM @accintouch.bsky.social @thornsberryjd.bsky.social

011

Joshua Thornsberry @thornsberryjd.bsky.social · 30/03/2025

EquiOx at #ACC25 confirms it: pulse oximeters don’t perform equally across skin tones—especially critically ill patients Wellstar’s, Dr. Paul Douglass shared insight on the need for equity in device validation #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

065

Joshua Thornsberry @thornsberryjd.bsky.social · 30/03/2025

MIGHTy-Heart took on gaps in HF care transitions. ✴️ 2,003 enrolled → MIH vs. TOCC ✴️ No difference in 30-day outcomes ✴️ Younger patients & women saw more benefit. Impressive representation: 52% women, 47% Black #ACC25 #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

024

Reposted by Joshua Thornsberry

Katie Kalvaitis @katiekalvaitis.bsky.social · 30/03/2025

🔥Hot off the press: Highlights from day 1 at #ACC25 #CardioSky 📌 WARRIOR 📌 STRIDE 📌 API-CAT 📌 SOUL 📌 RIVAWAR 📌 & more in the link www.healio.com/news/cardiol...

healio.com

023

Reposted by Joshua Thornsberry

Stephen Jenkins @sjenkinsmd.bsky.social · 30/03/2025

Among persons with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than placebo #MedSky #CardioSky #NephSky www.nejm.org/doi/full/10....

nejm.org

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes | NEJM

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ca...

042

Reposted by Joshua Thornsberry

Katie Kalvaitis @katiekalvaitis.bsky.social · 30/03/2025

More from day 1 #ACC25 … 📌 WARRIOR = the largest study of women with suspected ischemia with nonobstructive coronary disease 📌 Intensive medical therapy did not prevent 🫀 events for women with INOCA 📌 “This trial should not be considered a negative trial” www.healio.com/news/cardiol...

healio.com

Intensive medical therapy does not help or harm women with chest pain: WARRIOR

CHICAGO — Among women with suspected ischemia with nonobstructive coronary disease, an intensive medical therapy strategy did not reduce risk for major adverse CV events at 5 years compared with...

021

Reposted by Joshua Thornsberry

Parham Eshtehardi MD @cardioobdoc.bsky.social · 29/03/2025

Today at 4:30PM Don’t miss #ACC25 #CardioObstetrics Meet-Up

284

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

📆 Mark your calendars for Monday at #ACC25! Wellstar MCG presents a high-stakes case: RotaWire entrapment, fracture, and retrieval—titled “When It Rains It Pours.” ☔️💙 You won’t want to miss this one! #WellstarCVteam #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social

024

Reposted by Joshua Thornsberry

American College of Cardiology @accintouch.bsky.social · 29/03/2025

An oral formulation of semaglutide lowered the risk major adverse cardiovascular events by 14% in four years, with no change in safety profile compared to placebo, according to the SOUL study. #ACC25 Read the journal scan to learn more: bit.ly/3QTpizK #CardioSky #MedSky

0108

Reposted by Joshua Thornsberry

American College of Cardiology @accintouch.bsky.social · 29/03/2025

DAPA-TAVI: The #SGLT2 inhibitor dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening #HeartFailure in older adults w/ #vhdAS undergoing TAVI, resulting in a 28% relative risk ↘️. #ACC25 More: bit.ly/4cfLNsy #cvSurg #CardioSky #MedSky

11610

Reposted by Joshua Thornsberry

Brendon Neuen @brendonneuen.bsky.social · 29/03/2025

In SOUL, 2596/9650 (26.9%) participants were receiving SGLT2i at baseline (largest CVOT of combined GLP-1/SGLT2 to date) The effect of oral semaglutide on cardiovascular outcomes was consistent, regardless of SGLT2i use #ACC25 www.ahajournals.org/doi/abs/10.1...

086

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

Key takeaways from the CCKE for NPs & PAs session at #ACC25: • More than a test—it’s a career milestone • Prep with purpose, not panic • Exam day success = strategy + mindset #Cardiology #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

145

Reposted by Joshua Thornsberry

Cate Enstrom @jeannecate.bsky.social · 29/03/2025

Hard to do a clinical trial during a pandemic + suboptimal adherence and contamination but good to see a focus on women!

021

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

WARRIOR: A neutral trial, but key insights for women with INOCA. 🔹 2,476 enrolled (60% target) 🔹 High angina burden 🔹 SBP ≤120 mmHg may reduce angina 🔹 Future potential with ACEI/ARB + statins #ACC25 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

155

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

📸 Dr. Douglass on the big screen at #ACC25! As Chair of the ACC Task Force on Health Equity, his leadership is moving us closer to true equity in heart care. 💙 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

064

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

Science is booming at #ACC25 —17% more submissions than past years! 50+ clinical trial sessions, including late-breakers and featured research. Next up: • WARRIOR • STRIDE • API-CAT #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

045

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

Inspiring #ACC25 keynote by Cathleen Biga: 🫀 Embrace lifelong learning, AI, and health equity. 🫀 Protect patient access. 🫀 Honor those before us by writing the future—together. #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

043

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

👊🏻 Powerful start to #ACC25 with ACC President Cathleen Biga’s message: Embrace the CV team. Transform heart health for all. Grateful to witness leadership that champions collaboration and equity. #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

063

Joshua Thornsberry @thornsberryjd.bsky.social · 29/03/2025

📣 The doors are open—ACC.25 has officially begun! Kicking things off with the Opening Showcase, featuring Cathleen Biga & Kathryn Berlacher. Let’s make it a weekend to remember! #ACC25 #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

022

Reposted by Joshua Thornsberry

American College of Cardiology @accintouch.bsky.social · 25/03/2025

Artie’s all packed—are you? 🎒 📱 #ACC25 App ✅ Pro Tip: Make sure to download the app & set ⏰ for your must-attend sessions! 💻 Laptop/Notebook ✅ 👟 Comfy Shoes ✅ 💙 ACC Blue for March 31 ✅ ⚡️ Excitement & Energy! ✅ 4️⃣ days to go! What's your must-have for ACC.25? 🤔 #CardioSky #MedSky

0174

Reposted by Joshua Thornsberry

NEJM.org @nejm.org · 28/03/2025

Whether intensive systolic blood-pressure control or standard control is better for cardiovascular risk reduction in patients with type 2 #diabetes has been unclear. Research findings are summarized in a new Quick Take video. youtu.be/5FxxqoUFaac #MedSky #CardioSky

youtu.be

Intensive Blood-Pressure Control in Type 2 Diabetes | NEJM

YouTube video by NEJM Group

174

Reposted by Joshua Thornsberry

JACC Journals @jaccjournals.bsky.social · 28/03/2025

💡 Dr. Sandra Oliver-McNeil highlights 🔑 markers of quality research design: 🔹What types of studies are being conducted? 🔹Is the data free from bias? 🔹Were variables and confounding factors properly studied? 🔹Are the results valid and reliable? #ACC25 #JACC

054

Reposted by Joshua Thornsberry

JACC Journals @jaccjournals.bsky.social · 28/03/2025

The energy was high diving into Hands-on Workshop 1 right after Dr. Oliver-McNeil’s presentation! You’re already tackling a #JACC #TAVR clinical case, applying real-world insights and enhancing your skills 💡 #ACC25 @vivekkulkarni.bsky.social

034

Reposted by Joshua Thornsberry

American Heart Association Journals @ahajournals.bsky.social · 28/03/2025

See what's happening at the #AHAJournals! #ACC25 Sign up for alerts for the Switchboard blog at AHAJournals.org #Cardiosky

ahajournals.org

034

Reposted by Joshua Thornsberry

Tabitha G Moe, MD FACC @achddoc.bsky.social · 28/03/2025

Breakouts Difficult discussions best practices #ACC25

013

Reposted by Joshua Thornsberry

Christopher Steelman @cathlabedu.bsky.social · 27/03/2025

I’m thrilled to be a #ACC25 Social Media Ambassador! Follow me for live Cardiovascular Team Section updates. See you in Chicgo!! #ACCCVT #ACC25

162

Joshua Thornsberry @thornsberryjd.bsky.social · 28/03/2025

Want to crush #ACC25? 📲 Download the ACC.25 mobile app! It’s your hub for sessions, schedules & networking. Let’s make this the most connected conference yet! 💙 apps.apple.com/us/app/acc-2... #ACCCVT #CardioSky #WellstarCVteam @accintouch.bsky.social @jaccjournals.bsky.social

012

Joshua Thornsberry @thornsberryjd.bsky.social · 28/03/2025

✈️ Hello from McCormick Place! #ACC25 is about to kick off and I’m here as a Social Media Ambassador—ready to soak in every moment. Let’s make this unforgettable! 💙 #ACCCVT #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social

052

Joshua Thornsberry @thornsberryjd.bsky.social · 12/03/2025

💙 #ACC25 will unveil groundbreaking trials that will reshape cardiovascular care. Don't miss the research that could shift guidelines & improve outcomes! 🔗 Late-Breakers: accscientificsession.acc.org/en/Plan-Your... #ACC25 #ACCCVT #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social

074

Reposted by Joshua Thornsberry

Parham Eshtehardi MD @cardioobdoc.bsky.social · 05/03/2025

Getting ready for #ACC25? ✅ Download #ACC25 app apps.apple.com/us/app/acc-2... ✅ Follow #ACC25 ambassadors bsky.app/profile/did:... #CardioSky @accintouch.bsky.social @jaccjournals.bsky.social @saraersozlu.bsky.social @thornsberryjd.bsky.social @cathlabedu.bsky.social @bakhshihooman.bsky.social

097